Glaxosmithkline Biologicals
Plant certified by the Brazilian health regulator (ANVISA)
ANVISA, the Brazilian health regulator, holds a valid Good Manufacturing Practice certificate for this plant, covering biological active pharmaceutical ingredients, valid until 2027-07-03. The certificate is issued after an inspection of the plant itself, which is why a foreign regulator names this site: goods made here are allowed on the Brazilian market. Process number 25351046822201815.
- Type
- Manufacturer
- Location
- Singapore
- Categories
- 의약품 제조
- Markets
- 싱가포르, 브라질
Listed in a source registry
Verified facts
- gmp-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- sanctions-clear (green), checked 2026-08-24 OpenSanctions
- debarment-clear (green), checked 2026-08-24 OpenSanctions
- lei-lapsed (amber), checked 2026-08-24 GLEIF
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)